Tampa, FL, March 14, 2024 (GLOBE NEWSWIRE) — SafeGuard Surgical, a leading medical technology company focused on life-saving biodegradable solutions, announced today a major milestone in its mission to improve global healthcare. The U.S. Food and Drug Administration (FDA) has granted “Breakthrough” designation to SafeGuard Surgical’s patented biodegradable stent, LeakGuardTM. This rare honor and recognition by the FDA has only ever been bestowed upon approximately 800 medical devices.
More Young People Than Ever Will Get Colorectal Cancer This Year
Colon and rectal cancers are increasing among people younger than 50. Experts have a few ideas about why... READ THE FULL ARTICLE